Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis

被引:18
作者
Abu-Issa, R
Eichele, G
Youssoufian, H
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[4] Baylor Coll Med, Dev Biol Program, Houston, TX 77030 USA
关键词
D O I
10.1182/blood.V94.2.818.414k33_818_824
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
About 80% of all cases of Fanconi anemia (FA) can be accounted for by complementation groups A and C. To understand the relationship between these groups, we analyzed the expression pattern of the mouse FA group-A gene (Fanca) during embryogenesis and compared it with the known pattern of the group-C gene (Fanca). Northern analysis of RNA from mouse embryos at embryonic days 7, 11, 15, and 17 showed a predominant 4.5 kb band in all stages. By in situ hybridization, Fanca transcripts were found in the whisker follicles, teeth, brain, retina, kidney, liver, and limbs. There was also stage-specific variation in Fanca expression, particularly within the developing whiskers and the brain. Some tissues known to express Fancc (eg, gut) failed to show Fanca expression. These observations show that (1) Fanca is under both tissue- and stage-specific regulation in several tissues; (2) the expression pattern of Fanca is consistent with the phenotype of the human disease; and (3) Fanca expression is not necessarily coupled to that of Fancc. The presence of distinct tissue targets for FA genes suggests that some of the variability in the clinical phenotype can be attributed to the complementation group assignment. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:818 / 824
页数:7
相关论文
共 34 条
  • [1] ALBRECHT U, 1997, HUMAN GENOME METHODS, P93
  • [2] Positional cloning of the Fanconi anaemia group A gene
    Apostolou, S
    Whitmore, SA
    Crawford, J
    Lennon, G
    Sutherland, GR
    Callen, DF
    Ianzano, L
    Savino, M
    DApolito, M
    Notarangelo, A
    Memeo, E
    Piemontese, MR
    Zelante, L
    Savoia, A
    Gibson, RA
    Tipping, AJ
    Morgan, NV
    Hassock, S
    Jansen, S
    deRavel, TJ
    VanBerkel, C
    Pronk, JC
    Easton, DF
    Mathew, CG
    Levran, O
    Verlander, PC
    Batish, SD
    Erlich, T
    Auerbach, AD
    CletonJansen, AM
    Moerland, EW
    Cornelisse, CJ
    Doggett, NA
    Deaven, LL
    Moyzis, RK
    [J]. NATURE GENETICS, 1996, 14 (03) : 324 - 328
  • [3] BAYER SA, 1992, NEOCORTICAL DEV
  • [4] HEMATOLOGIC ABNORMALITIES IN FANCONI-ANEMIA - AN INTERNATIONAL FANCONI-ANEMIA REGISTRY STUDY
    BUTTURINI, A
    GALE, RP
    VERLANDER, PC
    ADLERBRECHER, B
    GILLIO, AP
    AUERBACH, AD
    [J]. BLOOD, 1994, 84 (05) : 1650 - 1655
  • [5] Fine exon-intron structure of the Fanconi anemia group A (FAA) gene and characterization of two genomic deletions
    Centra, M
    Memeo, E
    d'Apolito, M
    Savino, M
    Ianzano, L
    Notarangelo, A
    Liu, JM
    Doggett, NA
    Zelante, L
    Savoia, A
    [J]. GENOMICS, 1998, 51 (03) : 463 - 467
  • [6] Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia
    Chen, M
    Tomkins, DJ
    Auerbach, W
    McKerlie, C
    Youssoufian, H
    Liu, L
    Gan, O
    Carreau, M
    Auerbach, A
    Groves, T
    Guidos, CJ
    Freedman, MH
    Cross, J
    Percy, DH
    Dick, JE
    Joyner, AL
    Buchwald, M
    [J]. NATURE GENETICS, 1996, 12 (04) : 448 - 451
  • [7] DAVIDSON P, 1952, J ANAT, V86, P342
  • [8] The Fanconi anaemia group G gene FANCG is identical with XRCC9
    de Winter, JP
    Waisfisz, Q
    Rooimans, MA
    van Berkel, CGM
    Bosnoyan-Collins, L
    Alon, N
    Carreau, M
    Bender, O
    Demuth, I
    Schindler, D
    Pronk, JC
    Arwert, F
    Hoehn, H
    Digweed, M
    Buchwald, M
    Joenje, H
    [J]. NATURE GENETICS, 1998, 20 (03) : 281 - 283
  • [9] MOUSE EMBRYONIC HEMATOPOIESIS
    DZIERZAK, E
    MEDVINSKY, A
    [J]. TRENDS IN GENETICS, 1995, 11 (09) : 359 - 366
  • [10] FANCONI G., 1967, SEMINARS HAMATOL, V4, P233